glp 1 heart rate and health behavior responses to GLP-1 receptor agonists: a 12-wk study using wearable technology and causal inference | American Journal of Physiology-Heart and Circulatory Physiology The conversation around GLP-1 medications

See All from Calibrate Related Articles See All Supporting Frontline Workers: Why Weight Loss Solutions Must Be Customizable by CalibrateMarch 18, 2026 Oral GLP-1s Are Here And What This Means to Employers by CalibrateFebruary 11, 2026

The introduction of tirzepatide, the first dual agonist targeting both the GLP-1R and the glucose-dependent insulinotropic polypeptide (GIP) receptor, represents a new frontier in incretin-based therapy (Syed, 2022

Cost-effectiveness and health economic implications The elevated cost of acquisition of GLP-1 receptor agonists convey major challenges for healthcare systems, with yearly treatment expenses between $10,000 and $15,000 USD, markedly surpassing those of conventional diabetic drugs (Kong et al

Prklinische Forschung : Tierversuche belegen, dass GLP-1-Agonisten das Suchverhalten bei Nagetiermodellen fr Kokain- und Opioidabhngigkeit reduzieren knnen

Measurement of gut hormonal peptides in biopsies from human stomach and proximal small intestine

The Facebook page for a "Dr